Related Experiment Video
Updated: Aug 3, 2026
12:17
The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
Published on: August 2, 2017
Plasma placenta growth factor levels in midtrimester pregnancies
M L Tjoa1, J M van Vugt, M A Mulders
1Molecular Biology Laboratory, Department of Clinical Chemistry, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands.
Obstetrics and Gynecology
|September 29, 2001
Summary
Reduced placenta growth factor (PlGF) levels in early pregnancy may indicate a higher risk for developing preeclampsia and intrauterine growth restriction. This finding suggests PlGF could be a valuable biomarker for predicting these pregnancy complications.
Area of Science:
- Reproductive Medicine
- Biomarkers in Pregnancy
- Maternal-Fetal Medicine
Background:
- Preeclampsia and intrauterine growth restriction (IUGR) are significant causes of perinatal morbidity and mortality.
- Previous research indicates lower placenta growth factor (PlGF) levels in preeclamptic pregnancies.
- The predictive value of PlGF before clinical manifestation of these conditions remains to be fully elucidated.
Purpose of the Study:
- To investigate if placenta growth factor (PlGF) levels are decreased prior to the clinical onset of preeclampsia.
- To determine if PlGF levels are reduced in pregnancies complicated by intrauterine growth restriction (IUGR).
- To assess the potential of PlGF as an early predictive biomarker for preeclampsia and IUGR.
Main Methods:
- A longitudinal study involving 101 plasma samples from 72 pregnant women (gestational weeks 11-21).
- Retrospective analysis of placenta growth factor (PlGF) levels using enzyme-linked immunosorbent assay (ELISA).
- Correlation analysis between PlGF plasma concentrations and pregnancy outcomes (preeclampsia, IUGR).
Main Results:
- Significantly lower placenta growth factor (PlGF) levels were observed between weeks 17-21 in women who later developed preeclampsia (n=10) compared to controls (n=25, P=.004).
- Women with intrauterine growth restriction (IUGR) (n=5) also exhibited low PlGF levels.
- Analysis included 44 uncomplicated pregnancies, 18 with preeclampsia, and 10 with IUGR.
Conclusions:
- Plasma placenta growth factor (PlGF) levels are decreased before preeclampsia becomes clinically apparent.
- The findings suggest PlGF may serve as a useful biomarker for assessing the risk of developing preeclampsia and intrauterine growth restriction.
- Early detection of low PlGF could aid in timely interventions for high-risk pregnancies.
